Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Macrophage TREM2 is a triglyceride-rich lipoprotein receptor that undergoes shedding in prediabetic hepatic steatosis
Jingjing Tang, Jenny E. Kanter, Baohai Shao, Masami Shimizu-Albergine, Farah Kramer, Ah Reum Khang, Jason Luo, Huaqing Zheng, Alan Tran, Jocelyn Cervantes, Jeremy M. Frey, Mauricio D. Dorfman, Cheng-Chieh Hsu, Laura J. den Hartigh, Tomas Vaisar, Brandon S.J. Davies, Adam E. Mullick, George N. Ioannou, Gordon I. Smith, Samuel Klein, Nicholas O. Davidson, Karin E. Bornfeldt
Jingjing Tang, Jenny E. Kanter, Baohai Shao, Masami Shimizu-Albergine, Farah Kramer, Ah Reum Khang, Jason Luo, Huaqing Zheng, Alan Tran, Jocelyn Cervantes, Jeremy M. Frey, Mauricio D. Dorfman, Cheng-Chieh Hsu, Laura J. den Hartigh, Tomas Vaisar, Brandon S.J. Davies, Adam E. Mullick, George N. Ioannou, Gordon I. Smith, Samuel Klein, Nicholas O. Davidson, Karin E. Bornfeldt
View: Text | PDF
Research Article Metabolism Vascular biology

Macrophage TREM2 is a triglyceride-rich lipoprotein receptor that undergoes shedding in prediabetic hepatic steatosis

  • Text
  • PDF
Abstract

Prediabetes is associated with increased production of triglyceride-rich lipoproteins (TRLs), cardiovascular disease (CVD), and hepatic steatosis, which is linked to increased plasma levels of soluble TREM2 (sTREM2), the shed domain of TREM2 (triggering receptor expressed on myeloid cells 2). Whether and how TREM2 shedding contributes to elevated TRLs is unknown. By complementary analyses of individuals with prediabetes and hepatic steatosis and preclinical models, we show that plasma sTREM2 levels correlate positively with plasma apolipoprotein C3 (APOC3), an apolipoprotein that slows TRL catabolism and predicts CVD risk. Individuals with prediabetes and hepatic steatosis had higher plasma concentrations of APOC3-rich TRLs 35 to 60 nm in diameter than healthy controls. Mouse models of prediabetes with hepatic steatosis revealed that the increased plasma concentrations of sTREM2, APOC3, and TRLs were due to activation of macrophage ADAM17, a TREM2 sheddase. Preserving macrophage full-length TREM2 protected against the elevated plasma APOC3, sTREM2, dyslipidemia, and atherosclerosis, whereas TREM2 deficiency increased APOC3, TRLs, and atherosclerosis. Mechanistically, full-length TREM2 mediates macrophage TRL uptake, preventing excessive hepatic APOC3-rich TRL release and atherosclerosis. Our findings identify macrophage TREM2 shedding as an upstream contributor to the elevated TRLs in hepatic steatosis, providing a mechanistic link between hepatic steatosis and CVD risk in prediabetes.

Authors

Jingjing Tang, Jenny E. Kanter, Baohai Shao, Masami Shimizu-Albergine, Farah Kramer, Ah Reum Khang, Jason Luo, Huaqing Zheng, Alan Tran, Jocelyn Cervantes, Jeremy M. Frey, Mauricio D. Dorfman, Cheng-Chieh Hsu, Laura J. den Hartigh, Tomas Vaisar, Brandon S.J. Davies, Adam E. Mullick, George N. Ioannou, Gordon I. Smith, Samuel Klein, Nicholas O. Davidson, Karin E. Bornfeldt

×

Figure 5

Macrophage TREM2 mediates TRL uptake.

Options: View larger image (or click on image) Download as PowerPoint
Macrophage TREM2 mediates TRL uptake.
(A) BMDMs from the indicated genot...
(A) BMDMs from the indicated genotypes were incubated in the presence of DiI-VLDL for 30 or 60 minutes or vehicle for 30 minutes. The cells were them immunostained with a goat anti-APOB antibody (Ab7616, 1:500 dilution) followed by a donkey anti-goat Alexa Fluor 488 antibody (green). Cell nuclei were stained with DAPI (blue) and DiI was visualized as red stain. Scale bar: 20 μm. (B) Quantification of DiI uptake/total cell number (nuclei). (C) Quantification of APOB uptake/total cell number (nuclei). Data are shown from 1 representative experiment repeated 3 times in independent cell isolates with similar results. (D) Liver sections from the 4 groups stained with antibodies against CLEC4F (Kupffer cell marker) and PLIN2 (lipid droplet marker). Scale bar: 20 μm. (E) Quantitation of PLIN2 colocalized with CLEC4F. (F) Quantification of CLEC4F area/45,000 μm2. Statistical analyses: 2-way ANOVA with Tukey’s multiple-comparison test (B and C), 1-way ANOVA with Tukey’s multiple-comparison test (E), Kruskal-Wallis with Dunn’s multiple-comparison test (F). See Supporting Data Values for group sizes and statistics.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts